ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e; vitamin k
Drug data last refreshed 4d ago · AI intelligence enriched 2w ago
M.V.I. ADULT is an intravenous multivitamin injection containing 13 essential vitamins (A, B-complex, C, D, E, and K) used to prevent or treat vitamin deficiencies in patients unable to take oral supplements. It is indicated for patients receiving parenteral nutrition or those with malabsorption syndromes requiring direct IV supplementation.
As a legacy parenteral nutrition supplement facing LOE, the product maintains stable institutional demand but offers limited growth opportunities for commercial expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Only 2 linked job openings reflect the product's mature, stable status with minimal headcount needs. Career opportunities are constrained to entry-level or specialized technical roles in manufacturing and operations rather than commercial or clinical advancement.
Worked on M.V.I. ADULT at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
2 open roles linked to this drug